Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt

Melanoma is one of the most common cancers, with an increasing incidence worldwide. Disease stage represents the most important prognosis factor; therefore, early diagnosis is essential for melanoma patients’ survival rates. Following the outbreak in China, the coronavirus disease 2019 (COVID-19) pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Villani, Alessia, Fabbrocini, Gabriella, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255447/
https://www.ncbi.nlm.nih.gov/pubmed/32468229
http://dx.doi.org/10.1007/s13555-020-00402-x
_version_ 1783539732616052736
author Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
author_facet Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
author_sort Villani, Alessia
collection PubMed
description Melanoma is one of the most common cancers, with an increasing incidence worldwide. Disease stage represents the most important prognosis factor; therefore, early diagnosis is essential for melanoma patients’ survival rates. Following the outbreak in China, the coronavirus disease 2019 (COVID-19) pandemic has spread all over the world and the majority of dermatological visits have been postponed. These measures could cause a delay in melanoma diagnosis and management leading to an increase of morbidity, mortality and healthcare costs. Herein we propose an alternative model of skin cancer screening and the organization of screening campaigns in order to detect malignant lesions early during this emergency period.
format Online
Article
Text
id pubmed-7255447
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-72554472020-05-28 Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano Dermatol Ther (Heidelb) Commentary Melanoma is one of the most common cancers, with an increasing incidence worldwide. Disease stage represents the most important prognosis factor; therefore, early diagnosis is essential for melanoma patients’ survival rates. Following the outbreak in China, the coronavirus disease 2019 (COVID-19) pandemic has spread all over the world and the majority of dermatological visits have been postponed. These measures could cause a delay in melanoma diagnosis and management leading to an increase of morbidity, mortality and healthcare costs. Herein we propose an alternative model of skin cancer screening and the organization of screening campaigns in order to detect malignant lesions early during this emergency period. Springer Healthcare 2020-05-28 /pmc/articles/PMC7255447/ /pubmed/32468229 http://dx.doi.org/10.1007/s13555-020-00402-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Commentary
Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title_full Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title_fullStr Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title_full_unstemmed Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title_short Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
title_sort melanoma screening days during the coronavirus disease 2019 (covid-19) pandemic: strategies to adopt
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255447/
https://www.ncbi.nlm.nih.gov/pubmed/32468229
http://dx.doi.org/10.1007/s13555-020-00402-x
work_keys_str_mv AT villanialessia melanomascreeningdaysduringthecoronavirusdisease2019covid19pandemicstrategiestoadopt
AT fabbrocinigabriella melanomascreeningdaysduringthecoronavirusdisease2019covid19pandemicstrategiestoadopt
AT costaclaudia melanomascreeningdaysduringthecoronavirusdisease2019covid19pandemicstrategiestoadopt
AT scalvenzimassimiliano melanomascreeningdaysduringthecoronavirusdisease2019covid19pandemicstrategiestoadopt

Ejemplares similares